The major listed pharmaceutical and bio companies were found to have significantly increased their R&D personnel over the past 3 years, during the COVID-19 pandemic. 9 out of 10 companies increased their research personnel, and the number increased by 25% during the past 3 years.

According to the Financial Supervisory Service on the 31st, the total number of research personnel in major listed companies in Korea increased by 11.7% from the previous year to reach 6,417. Among the listed biopharmaceutical companies, the 30 with the highest sales that own research personnel were reviewed for research.

Compared to before the COVID-19 outbreak, pharmaceutical companies in Korea have greatly increa